PL2934557T3 - Szczep bifidobacterium animalis ssp. animalis - Google Patents

Szczep bifidobacterium animalis ssp. animalis

Info

Publication number
PL2934557T3
PL2934557T3 PL13824023T PL13824023T PL2934557T3 PL 2934557 T3 PL2934557 T3 PL 2934557T3 PL 13824023 T PL13824023 T PL 13824023T PL 13824023 T PL13824023 T PL 13824023T PL 2934557 T3 PL2934557 T3 PL 2934557T3
Authority
PL
Poland
Prior art keywords
animalis
strain
ssp
bifidobacterium
bifidobacterium animalis
Prior art date
Application number
PL13824023T
Other languages
English (en)
Inventor
Sophie Legrain-Raspaud
Gianfranco Grompone
Sandrine Capronnier
Tamara Smokvina
Marie-Christine Degivry
Biliana Lesic
Michel Neunlist
Original Assignee
Compagnie Gervais Danone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compagnie Gervais Danone filed Critical Compagnie Gervais Danone
Publication of PL2934557T3 publication Critical patent/PL2934557T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/515Animalis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
PL13824023T 2012-12-18 2013-12-10 Szczep bifidobacterium animalis ssp. animalis PL2934557T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2012/057431 WO2014096901A1 (en) 2012-12-18 2012-12-18 Strain of bifidobacterium animalis ssp. animalis
EP13824023.9A EP2934557B1 (en) 2012-12-18 2013-12-10 Strain of bifidobacterium animalis ssp. animalis

Publications (1)

Publication Number Publication Date
PL2934557T3 true PL2934557T3 (pl) 2017-08-31

Family

ID=47633132

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13824023T PL2934557T3 (pl) 2012-12-18 2013-12-10 Szczep bifidobacterium animalis ssp. animalis

Country Status (17)

Country Link
US (1) US10064902B2 (pl)
EP (1) EP2934557B1 (pl)
JP (1) JP6197045B2 (pl)
KR (1) KR102146429B1 (pl)
CN (1) CN105025907B (pl)
AR (1) AR093916A1 (pl)
CA (1) CA2893822C (pl)
EA (1) EA030356B1 (pl)
ES (1) ES2621264T3 (pl)
HU (1) HUE032210T2 (pl)
MA (1) MA38174A1 (pl)
MX (1) MX358026B (pl)
PL (1) PL2934557T3 (pl)
PT (1) PT2934557T (pl)
TN (1) TN2015000259A1 (pl)
WO (2) WO2014096901A1 (pl)
ZA (1) ZA201504217B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3285785B1 (en) * 2015-04-23 2024-02-21 Compagnie Gervais Danone Composition for reducing intestinal gas production
RU2720983C2 (ru) * 2015-07-31 2020-05-15 Компани Жервэ Данон Способы приготовления ферментированных продуктов, включающих бифидобактерии
KR101910808B1 (ko) * 2016-11-28 2018-10-24 주식회사 쎌바이오텍 유산균 유래 p8 단백질 및 이의 항암 용도
CN107574133A (zh) * 2017-05-05 2018-01-12 南昌大学 动物双歧杆菌m2017064及其在缓解慢性肾脏疾病药物的应用
KR101964883B1 (ko) 2017-10-26 2019-04-02 서울대학교 산학협력단 한국 유아 분변 유래의 베타-갈락토시데이즈 활성이 우수한 신규 균주 비피도박테리움 애니멀리스 ldtm8101
KR102238519B1 (ko) * 2018-12-28 2021-04-13 (주)메디톡스 외래 단백질을 발현하는 미생물, 및 그의 용도
BR112021026278A2 (pt) * 2019-06-27 2022-03-03 Il Dong Pharma Composições farmacêuticas, composições alimentícias, usos de uma composição, método de tratamento da doença inflamatória intestinal e método para inibir a inflamação
CN115252653A (zh) * 2020-01-22 2022-11-01 内蒙古蒙牛乳业(集团)股份有限公司 一种润肠通便的动物双歧杆菌及其应用与制剂
KR20210129516A (ko) * 2020-04-20 2021-10-28 주식회사 리비옴 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
CN114717132B (zh) * 2021-09-08 2023-07-07 青岛蔚蓝生物股份有限公司 一株具有预防和缓解便秘症状的乳双歧杆菌及其应用
KR102495386B1 (ko) * 2021-12-08 2023-02-06 ㈜새롬바이오 유산균을 이용한 저글루텐 밀가루 발효조성물, 이를 포함하는 식품첨가제 및 이를 포함하는 식품, 및 그 제조 방법
CN114350577B (zh) * 2022-03-17 2022-05-27 微康益生菌(苏州)股份有限公司 一种改善便秘的动物双歧杆菌乳亚种BLa36及其培养方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020044046A (ko) * 2001-07-30 2002-06-14 비앤아이티(주) 복합 생균제를 소재로 한 장기능 개선용 건강기능성식품
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2403510B1 (en) * 2009-03-05 2020-02-26 Probiotical S.p.A. Bacteria strains having a high anti-inflammatory activity
ES2436620T3 (es) * 2009-11-02 2014-01-03 Compagnie Gervais Danone Método para reducir la inflamación gastro-intestinal usando la bacteria Bifidobacterium animalis o un producto lácteo fermentado que comprende dicha bacteria
CA2787544C (en) * 2010-01-28 2019-07-09 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
WO2011148220A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving transepithelial resistance

Also Published As

Publication number Publication date
EA201591057A1 (ru) 2015-10-30
EP2934557A1 (en) 2015-10-28
MX358026B (es) 2018-08-02
AR093916A1 (es) 2015-06-24
US10064902B2 (en) 2018-09-04
WO2014097050A9 (en) 2014-11-06
CA2893822A1 (en) 2014-06-26
WO2014096901A1 (en) 2014-06-26
PT2934557T (pt) 2017-04-05
EP2934557B1 (en) 2017-01-04
KR102146429B1 (ko) 2020-08-20
CN105025907A (zh) 2015-11-04
CA2893822C (en) 2021-09-21
US20150320807A1 (en) 2015-11-12
MX2015007814A (es) 2015-08-20
EA030356B1 (ru) 2018-07-31
JP2016502842A (ja) 2016-02-01
ES2621264T3 (es) 2017-07-03
TN2015000259A1 (en) 2016-10-03
ZA201504217B (en) 2017-08-30
HUE032210T2 (hu) 2017-09-28
MA38174A1 (fr) 2018-03-30
JP6197045B2 (ja) 2017-09-13
CN105025907B (zh) 2019-05-31
KR20150095717A (ko) 2015-08-21
WO2014097050A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
ZA201504217B (en) Strain of bifidobacterium animalis ssp. animalis
HK1201208A1 (en) Probiotic bacteria
HK1206391A1 (en) Bioprotection using lactobacillus rhamnosus strains
HK1207116A1 (en) Novel strain of lactobacillus crispatus
HK1206390A1 (en) Bioprotection using lactobacillus paracasei strains
ZA201406925B (en) Biocontrol
HK1208067A1 (zh) 小容器
ZA201502685B (en) Capsules
ZA201300565B (en) Draft force sensor assembly
SG11201503097RA (en) Handleable calco-magnesian suspension
HK1206787A1 (en) Pha-producing genetically engineered pha
HK1212919A1 (zh) 疫苗
DK2892392T3 (en) Balance chair
EP2859940A4 (en) MICRO REACTOR
PL2794930T3 (pl) Nowy szczep lactobacillus mucosae
EP2881460A4 (en) CELL STRAIN OF MONACANTHIDAE
EP2821760A4 (en) ELECTROMAGNETIC FORCE BALANCE
ZA201502896B (en) Dispersible tablet
AU4722P (en) Sunburn xDisphyllum (Disphyma crassifolium ssp. clavellatum x Glottiphyllum longum)
AU343663S (en) Portion capsule
GB201220749D0 (en) Capsules
GB201222780D0 (en) Transforming genetic sequences
GB201222691D0 (en) Connect MDA
GB201218269D0 (en) Improved garment
GB201206799D0 (en) Improved garment